Find Disodium Hydrogen Phosphate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

ACTIVE PHARMA INGREDIENTS

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

300 RELATED EXCIPIENT COMPANIES

512EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 7558-79-4, Disodium phosphate, Sodium phosphate dibasic, Disodium hydrogenorthophosphate, Dibasic sodium phosphate, Acetest
Molecular Formula
HNa2O4P
Molecular Weight
141.959  g/mol
InChI Key
BNIILDVGGAEEIG-UHFFFAOYSA-L
FDA UNII
22ADO53M6F

Disodium Hydrogen Phosphate
1 2D Structure

Disodium Hydrogen Phosphate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
disodium;hydrogen phosphate
2.1.2 InChI
InChI=1S/2Na.H3O4P/c;;1-5(2,3)4/h;;(H3,1,2,3,4)/q2*+1;/p-2
2.1.3 InChI Key
BNIILDVGGAEEIG-UHFFFAOYSA-L
2.1.4 Canonical SMILES
OP(=O)([O-])[O-].[Na+].[Na+]
2.2 Other Identifiers
2.2.1 UNII
22ADO53M6F
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Dibasic Sodium Phosphate, Anhydrous

2. Disodium Acid Phosphate

3. Disodium Hydrogen Phosphate Anhydrous

4. Monosodium Dihydrogen Phosphate

5. Neutral Sodium Hydrogen Phosphate

6. Phosphoric Acid, Disodium Salt

7. Phosphoric Acid, Disodium Salt, 32p-labeled

8. Phosphoric Acid, Disodium Salt, Anhydrous

9. Phosphoric Acid, Disodium Salt, Dodecahydrate

10. Phosphoric Acid, Disodium Salt, Heptahydrate

11. Phosphoric Acid, Monosodium Salt

12. Phosphoric Acid, Monosodium Salt, Anhydrous

13. Phosphoric Acid, Sodium (2:3) Salt

14. Phosphoric Acid, Sodium Salt

15. Phosphoric Acid, Trisodium Salt

16. Phosphoric Acid, Trisodium Salt , 32p-labeled

17. Phosphoric Acid, Trisodium Salt , Dodecahydrate

18. Sodium Biphosphate

19. Sodium Dihydrogen Orthophosphate

20. Sodium Dihydrogen Phosphate

21. Sodium Hydrophosphate

22. Sodium Phosphate

23. Sodium Phosphate Monobasic Anhydrous

24. Sodium Phosphate, Dibasic

25. Sodium Phosphate, Dibasic (anhydrous)

26. Sodium Phosphate, Disodium Salt

27. Sodium Phosphate, Monobasic

28. Sodium Phosphate, Monobasic Anhydrous

29. Sodium Phosphate, Tribasic

30. Sodium Phosphate, Tribasic, Dodecahydrate

31. Trisodium Phosphate

32. Trisodium Phosphate Dodecahydrate

2.3.2 Depositor-Supplied Synonyms

1. 7558-79-4

2. Disodium Phosphate

3. Sodium Phosphate Dibasic

4. Disodium Hydrogenorthophosphate

5. Dibasic Sodium Phosphate

6. Acetest

7. Sodium Phosphate, Dibasic

8. Disodium Acid Phosphate

9. Disodium Hydrogenphosphate

10. Soda Phosphate

11. Phosphoric Acid, Disodium Salt

12. Exsiccated Sodium Phosphate

13. Disodium Orthophosphate

14. Sodium Hydrogenphosphate

15. Sodium Hydrogen Phosphate

16. Sodium Monohydrogen Phosphate

17. Fema No. 2398

18. Secondary Sodium Phosphate

19. Disodium;hydrogen Phosphate

20. Disodium Acid Orthophosphate

21. Sec-sodium Phosphate

22. Disodium Phosphate, Anhydrous

23. Disodium Monohydrogen Phosphate

24. Disodium Hydrogen Phosphate, Anhydrous

25. Hydrogen Disodium Phosphate

26. Sodium Phosphate, Dibasic, Anhydrous

27. Sodium Phosphate, Dibasic (anhydrous)

28. Sodium Phosphate, Dibasic Anhydrous

29. Sodium Phosphate Dibasic Anhydrous

30. Na2hpo4

31. Phosphoric Acid, Sodium Salt (1:2)

32. Disodium Hydrogen Monophosphate

33. 22ado53m6f

34. Disodium Hydrogen Orthophosphate

35. Ins No.339(ii)

36. Dsp

37. Chebi:34683

38. Ins-339(ii)

39. Dibasic Sodium Phosphate Anhydrous

40. Dibasic Sodium Phosphate, Anhydrous

41. E-339(ii)

42. Mfcd00003496

43. Phosphoric Acid, Disodium Salt, Anhydrous

44. Phosphate Of Soda

45. Monohydrogen Sodium Phosphate

46. Caswell No. 778

47. Disodium Hydrophosphate

48. Fema Number 2398

49. Fleet Enema

50. Natriumphosphat [german]

51. Sodium Phosphate (nahpo4)

52. Sodium Phosphate, Exsiccated

53. Ccris 5931

54. Hsdb 376

55. Sodium Orthophosphate, Secondary

56. Sodium Acid Phosphate, Anhydrous

57. Einecs 231-448-7

58. Potassium Phosphate Monobasic/sodium Phosphate Dibasic

59. Epa Pesticide Chemical Code 076403

60. Sodium Monohydrogen Phosphate (2:1:1)

61. Unii-22ado53m6f

62. Disodium Phospahte

63. Sodiumphosphatedibasic

64. Disodiumhydrogenphosphate

65. Sodium Hydrogen-phosphate

66. Disodium Hydrogen-phosphate

67. Buffer Salt, Ph 6.87

68. Buffer Salt, Ph 7.42

69. Ec 231-448-7

70. Sorensen's Sodium Phosphate

71. Di-sodium Hydrogen Phosphate

72. Phosphoric Acid Disodium Salt

73. Sodium Hydrogen Orthophosphate

74. Sodium Phosphate, Unspecified

75. Sodium Phosphate [fhfi]

76. Dtxsid1026039

77. Disodium Phosphate [hsdb]

78. Disodium Phosphate [inci]

79. Sodium Phosphate,dibasic,anhydrous

80. Bcp13559

81. Sodium Hydrogen Phosphate, Anhydrous

82. Sodium Phosphate Dibasic, Acs Grade

83. Disodium Hydrogen Phosphate Submicron

84. Disodium Phosphate (fragrance Grade)

85. Akos015902440

86. Akos015950661

87. Disodium Phosphate (industrial Grade)

88. Ccg-266159

89. Db14502

90. Sodium Phosphate, Dibasic [mi]

91. Disodium Phosphate [ep Monograph]

92. Sodium Phosphate Dibasic [who-dd]

93. Sodium Phosphate Dibasic, Biochemical Grade

94. B7293

95. Ft-0625321

96. Sodium Phosphate Dibasic, Trace Metals Grade

97. A937532

98. Q418448

99. Sodium Phosphate, Dibasic, Anhydrous [ii]

100. Sodium Phosphate,dibasic,anhydrous [vandf]

101. Phosphoric-32p Acid,disodium Salt (8ci,9ci)

102. Disodium Hydrogen Orthophosphate;sodium Hydrogen Phosphate

103. Sodium Phosphate, Dibasic Anhydrous [orange Book]

104. Sodium Phosphate, Dibasic, Anhydrous [orange Book]

105. Visicol Component Sodium Phosphate, Dibasic Anhydrous

106. Osmoprep Component Sodium Phosphate, Dibasic Anhydrous

107. Sodium Phosphate, Dibasic Anhydrous Component Of Visicol

108. Sodium Phosphate, Dibasic Anhydrous Component Of Osmoprep

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 141.959 g/mol
Molecular Formula HNa2O4P
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count0
Exact Mass141.94078407 g/mol
Monoisotopic Mass141.94078407 g/mol
Topological Polar Surface Area83.4 Ų
Heavy Atom Count7
Formal Charge0
Complexity46.5
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Drug and Medication Information
4.1 Therapeutic Uses

Cathartics

National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)


Sodium Phosphates Injection, USP, ... is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific parenteral fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. /Included in US product label/

US Natl Inst Health; DailyMed. Current Medication Information for Sodium Phosphates (Sodium Phosphate) Injection (June 2006). Available from, as of March 20, 2009: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=1758


Visicol tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older. /Included in US product label/

US Natl Inst Health; DailyMed. Current Medication Information for VISICOL (sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous) tablet (November 2008). Available from, as of March 20, 2009: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=1758


Although sodium and/or potassium phosphates have been used in the treatment of hypercalcemia, USP medical advisory panels do not recommend this use since these medications have been replaced by safer and more effective agents. /Phosphates/

Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 2453


For more Therapeutic Uses (Complete) data for DISODIUM HYDROGEN PHOSPHATE (14 total), please visit the HSDB record page.


4.2 Drug Warning

/BOXED WARNING/ There have been rare, but serious reports of acute phosphate nephropathy in patients who received oral sodium phosphate products for colon cleansing prior to colonoscopy. Some cases have resulted in permanent impairment of renal function and some patients required long-term dialysis. While some cases have occurred in patients without identifiable risk factors, patients at increased risk of acute phosphate nephropathy may include those with increased age, hypovolemia, increased bowel transit time (such as bowel obstruction), active colitis, or baseline kidney disease, and those using medicines that affect renal perfusion or function (such as diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and possibly nonsteroidal anti-inflammatory drugs (NSAIDs)).

US Natl Inst Health; DailyMed. Current Medication Information for Osmoprep (sodium phosphate, monobasic, monohydrate, sodium phosphate, dibasic anhydrous) tablet (Updated: March 2013). Available from, as of April 24, 2015: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b46c0b17-c49b-4791-913f-3e6e1fdbe88e


FDA has become aware of reports of acute phosphate nephropathy, a type of acute kidney injury, associated with the use of oral sodium phosphate products (OSP) for bowel cleansing prior to colonoscopy or other procedures. These products include the prescription products, Visicol and OsmoPrep, and OSPs available over-the-counter without a prescription as laxatives (e.g., Fleet Phospho-soda). In some cases when used for bowel cleansing, these serious adverse events have occurred in patients without identifiable factors that would put them at risk for developing acute kidney injury. We cannot rule out, however, that some of these patients were dehydrated prior to ingestion of OSPs or they did not drink sufficient fluids after ingesting OSP. Acute phosphate nephropathy is a form of acute kidney injury that is associated with deposits of calcium-phosphate crystals in the renal tubules that may result in permanent renal function impairment. Acute phosphate nephropathy is a rare, serious adverse event that has been associated with the use of OSPs. The occurrence of these events was previously described in an Information for Healthcare Professionals sheet and an FDA Science Paper issued in May 2006. Additional cases of acute phosphate nephropathy have been reported to FDA and described in the literature since these were issued. Individuals who appear to have an increased risk of acute phosphate nephropathy following the use of OSPs include persons: who are over age 55; who are hypovolemic or have decreased intravascular volume; who have baseline kidney disease, bowel obstruction, or active colitis; and who are using medications that affect renal perfusion or function (such as diuretics, angiotensin converting enzyme [ACE] inhibitors, angiotensin receptor blockers [ARBs], and possibly nonsteroidal anti-inflammatory drugs [NSAIDs]). As a result of new safety information received, FDA is requiring the manufacturer of Visicol and OsmoPrep, the two OSPs available by prescription only, to add a Boxed Warning to the labeling for these products. FDA is also requiring that the manufacturer develop and implement a risk evaluation and mitigation strategy (REMS), which will include a Medication Guide, to ensure that the benefits of these products outweigh the risk of acute phosphate nephropathy, and to conduct a postmarketing clinical trial to further assess the risk of acute kidney injury with use of these products.

FDA/CDER; FDA Alert: Oral Sodium Phosphate (OSP) Products for Bowel Cleansing (marketed as Visicol and OsmoPrep, and oral sodium phosphate products available without a prescription) (12/11/2008). Available from: https://www.fda.gov/cder/drug/infopage/OSP_solution/default.htm as of March 20,2009.


This phosphate should not be confused with tribasic sodium phosphate which is very alkaline and has caustic action.

Osol, A. (ed.). Remington's Pharmaceutical Sciences. 16th ed. Easton, Pennsylvania: Mack Publishing Co., 1980., p. 745


Oral administration is safer, but careful monitoring of serum electrolyte levels and renal function is necessary. Nausea, vomiting, and diarrhea may occur and may be dose dependent. Concomitant use of antacids containing aluminum and/or magnesium should be avoided, because they may bind phosphate and prevent it absorption (calcium antacids also may bind phosphate, and it is assumed that these agents are not given to hypercalcemic patients). /Monobasic or dibasic sodium or potassium phosphate/

American Medical Association, Department of Drugs. Drug Evaluations. 6th ed. Chicago, Ill: American Medical Association, 1986., p. 897


For more Drug Warnings (Complete) data for DISODIUM HYDROGEN PHOSPHATE (57 total), please visit the HSDB record page.


4.3 Minimum/Potential Fatal Human Dose

The estimated fatal dose of sodium phosphates is 50 g.

Dreisbach, R.H. Handbook of Poisoning. 12th ed. Norwalk, CT: Appleton and Lange, 1987., p. 212


4.4 Drug Indication

Used to treat constipation or to clean the bowel before a colonoscopy.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Sodium phosphate inceases fecal water content to increase mobility through the large intestine.


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Increased Large Intestinal Motility [PE]
5.3 Absorption, Distribution and Excretion

Absorption

Tmax for phosphate absorption with orally administered liquid sodium phosphate is 1-3h.


... Phosphates (dibasic and monobasic sodium phosphate) are slowly and incompletely absorbed. /Dibasic and Monobasic Sodium phosphate/

Gosselin, R.E., H.C. Hodge, R.P. Smith, and M.N. Gleason. Clinical Toxicology of Commercial Products. 4th ed. Baltimore: Williams and Wilkins, 1976., p. II-83


Net phosphorus absorption may occur in the small intestine in some species but is primarily a function of the colon in horses. /Phosphorus/

Booth, N.H., L.E. McDonald (eds.). Veterinary Pharmacology and Therapeutics. 5th ed. Ames, Iowa: Iowa State University Press, 1982., p. 640


Elimination: Renal (90%) and fecal (10%). /Phosphates/

Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 2453


Ingested phosphates are absorbed from the gastrointestinal tract. However, the presence of large amounts of calcium or aluminum may lead to formation of insoluble phosphate and reduce the net absorption. Vitamin D stimulates phosphate absorption. /Phosphates/

Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 2453


For more Absorption, Distribution and Excretion (Complete) data for DISODIUM HYDROGEN PHOSPHATE (9 total), please visit the HSDB record page.


5.4 Mechanism of Action

Sodium phosphate is thought to work by increasing the amount of solute present in the intestinal lumen thereby creating an osmotic gradient which draws water into the lumen.


At the renal distal tubule, the secretion of hydrogen by the tubular cell in exchange for sodium in the tubular urine converts dibasic phosphate salts to monobasic phosphate salts. Therefore, large amounts of acid can be excreted without lowering the pH of the urine to a degree that would block hydrogen transport by a high concentration gradient between the tubular cell and luminal fluid. /Phosphates/

Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 2453


DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - SOLUTION;IRRIGATION - 0.154MG/ML;0.9...DOSAGE - SOLUTION;IRRIGATION - 0.154MG/ML;0.92MG/ML;0.184MG/ML;0.2MG/ML;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/ML

USFDA APPLICATION NUMBER - 18469

read-more

DOSAGE - INJECTABLE;INJECTION - 3.68GM/1000ML...DOSAGE - INJECTABLE;INJECTION - 3.68GM/1000ML;3.05GM/1000ML;0.314GM/1000ML ;3.09GM/1000ML;6.34GM/1000ML;0.187GM/1000ML (5000ML)

USFDA APPLICATION NUMBER - 207026

read-more

DOSAGE - INJECTABLE;INJECTION - N/A/1000ML;3....DOSAGE - INJECTABLE;INJECTION - N/A/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;6.95GM/1000ML;0.187GM/1000ML (5000ML)

USFDA APPLICATION NUMBER - 207026

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Direct Compression

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Parenteral

read-more
read-more

Solubilizers

read-more
read-more

Taste Masking

read-more
read-more

Granulation

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Topical

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Emulsifying Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Empty Capsules

read-more
read-more

Coloring Agents

read-more
read-more

Vegetarian Capsules

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty